Ultimovacs ASA

OB:ULTI Stock Report

Market Cap: NOK 58.8m

Ultimovacs Future Growth

Future criteria checks 2/6

Ultimovacs is forecast to grow earnings and revenue by 30.7% and 40.7% per annum respectively. EPS is expected to grow by 83.3% per annum. Return on equity is forecast to be -27.8% in 3 years.

Key information

30.7%

Earnings growth rate

83.3%

EPS growth rate

Biotechs earnings growth2.4%
Revenue growth rate40.7%
Future return on equity-27.8%
Analyst coverage

Low

Last updated27 Aug 2024

Recent future growth updates

Recent updates

Companies Like Ultimovacs (OB:ULTI) Can Afford To Invest In Growth

Feb 21
Companies Like Ultimovacs (OB:ULTI) Can Afford To Invest In Growth

Ultimovacs (OB:ULTI) Is In A Strong Position To Grow Its Business

Oct 26
Ultimovacs (OB:ULTI) Is In A Strong Position To Grow Its Business

Companies Like Ultimovacs (OB:ULTI) Are In A Position To Invest In Growth

Oct 05
Companies Like Ultimovacs (OB:ULTI) Are In A Position To Invest In Growth

Ultimovacs (OB:ULTI) Is In A Good Position To Deliver On Growth Plans

May 19
Ultimovacs (OB:ULTI) Is In A Good Position To Deliver On Growth Plans

Here's Why We're Not At All Concerned With Ultimovacs' (OB:ULTI) Cash Burn Situation

Jul 27
Here's Why We're Not At All Concerned With Ultimovacs' (OB:ULTI) Cash Burn Situation

We're Hopeful That Ultimovacs (OB:ULTI) Will Use Its Cash Wisely

Mar 23
We're Hopeful That Ultimovacs (OB:ULTI) Will Use Its Cash Wisely

Have Insiders Sold Ultimovacs ASA (OB:ULTI) Shares Recently?

Feb 13
Have Insiders Sold Ultimovacs ASA (OB:ULTI) Shares Recently?

Earnings and Revenue Growth Forecasts

OB:ULTI - Analysts future estimates and past financials data (NOK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026N/A-110-110-1101
12/31/202587-72-80-791
12/31/2024N/A-146-193-1801
6/30/2024N/A-179-180-180N/A
3/31/2024N/A-178-199-199N/A
12/31/2023N/A-189-190-190N/A
9/30/2023N/A-204-197-197N/A
6/30/2023N/A-186-196-196N/A
3/31/2023N/A-165-159-159N/A
12/31/2022N/A-168-168-168N/A
9/30/2022N/A-148-152-152N/A
6/30/2022N/A-153-145-145N/A
3/31/2022N/A-168-142-142N/A
12/31/2021N/A-165-126-126N/A
9/30/2021N/A-138-105-105N/A
6/30/2021N/A-126-102-102N/A
3/31/2021N/A-124-110-105N/A
12/31/2020N/A-121-114-108N/A
9/30/2020N/A-121-114-108N/A
6/30/2020N/A-108-102-97N/A
3/31/2020N/A-77-80-79N/A
12/31/2019N/A-61-63-63N/A
9/30/2019N/A-48-59-59N/A
6/30/2019N/A-48-57-56N/A
3/31/2019N/A-59-55-55N/A
12/31/2018N/A-55-51-50N/A
9/30/2018N/A-50-46-45N/A
6/30/2018N/A-42-38-38N/A
3/31/2018N/A-35N/A-32N/A
12/31/2017N/A-33N/A-27N/A
12/31/2016N/A-29N/A-31N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ULTI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ULTI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ULTI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ULTI's revenue (40.7% per year) is forecast to grow faster than the Norwegian market (1.9% per year).

High Growth Revenue: ULTI's revenue (40.7% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ULTI is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y